Dalbergioidin
(Synonyms:2',4',5,7-四羟基异黄烷酮;2’,4’,5,7-四羟基异黄烷酮;达尔伯汀;2',4',5,7-四羟基异黄烷酮标准品;2’,4’,5,7-四羟基异黄烷酮标准品,对照品)
目录号 : KE6050
CAS No. : 30368-42-4
纯度 : ≥95%
Dalbergioidin exhibits tyrosinase inhibitory activity with an IC50 of 20 mM. It shows a melanin biosynthesis inhibition zone in the culture plate of Streptomyces bikiniensis that has commonly been used as an indicator organism. Dalbergioidin protects MC3T3-E1 osteoblastic cells against H2O2-induced cell damage through activation of the PI3K/AKT/SMAD1 pathway, suggests that it may be useful in bone metabolism diseases, particularly osteoporosis. Dalbergioidin also ameliorates doxorubicin-induced renal fibrosis by suppressing the TGF-β signal pathway.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
生物活性 |
Dalbergioidin exhibits tyrosinase inhibitory activity with an IC50 of 20 mM. It shows a melanin biosynthesis inhibition zone in the culture plate of Streptomyces bikiniensis that has commonly been used as an indicator organism. Dalbergioidin protects MC3T3-E1 osteoblastic cells against H2O2-induced cell damage through activation of the PI3K/AKT/SMAD1 pathway, suggests that it may be useful in bone metabolism diseases, particularly osteoporosis. Dalbergioidin also ameliorates doxorubicin-induced renal fibrosis by suppressing the TGF-β signal pathway.
|
分子式 |
C15H12O6
|
分子量 |
288.25
|
CAS号 |
30368-42-4
|
中文名称 |
2’,4’,5,7-四羟基异黄烷酮
|
运输条件 |
Room temperature in continental US; may vary elsewhere.
|
储存方式 |
Store at -20˚C
|